Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Retrovirology

Showing results (951-960 of 1,647) with videos related to

Pageof 165
Sort By:
Retrovirology|March 29, 2008
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progressionMarie Borggren, Johanna Repits, Carlotta Kuylenstierna, et al.
Retrovirology|April 1, 2008
Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytesCorinne Barat, Caroline Gilbert, Michael Imbeault, et al.
Retrovirology|January 31, 2006
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccineJennifer D Watkins, Sophie Lancelot, Grant R Campbell, et al.
Retrovirology|January 18, 2006
Latency: the hidden HIV-1 challengeAlessandro Marcello
Retrovirology|January 10, 2006
A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading framesZachary Klase, Michael J Donio, Andrew Blauvelt, et al.
Retrovirology|February 5, 2008
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in PortugalJurgen Vercauteren, Koen Deforche, Kristof Theys, et al.
Retrovirology|February 5, 2008
Hitting HIV where it hidesAndrew I Dayton
Retrovirology|February 5, 2008
Early and transient reverse transcription during primary deltaretroviral infection of sheepCarole Pomier, Maria T Sanchez Alcaraz, Christophe Debacq, et al.
Retrovirology|April 23, 2008
Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cellsTetsuya Usui, Katsunori Yanagihara, Kunihiro Tsukasaki, et al.
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Pageof 165

Showing results (951-960 of 1,647) with videos related to

Sort By:
Pageof 165
Retrovirology|March 29, 2008
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progressionMarie Borggren, Johanna Repits, Carlotta Kuylenstierna, et al.
Retrovirology|April 1, 2008
Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytesCorinne Barat, Caroline Gilbert, Michael Imbeault, et al.
Retrovirology|January 31, 2006
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccineJennifer D Watkins, Sophie Lancelot, Grant R Campbell, et al.
Retrovirology|January 18, 2006
Latency: the hidden HIV-1 challengeAlessandro Marcello
Retrovirology|January 10, 2006
A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading framesZachary Klase, Michael J Donio, Andrew Blauvelt, et al.
Retrovirology|February 5, 2008
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in PortugalJurgen Vercauteren, Koen Deforche, Kristof Theys, et al.
Retrovirology|February 5, 2008
Hitting HIV where it hidesAndrew I Dayton
Retrovirology|February 5, 2008
Early and transient reverse transcription during primary deltaretroviral infection of sheepCarole Pomier, Maria T Sanchez Alcaraz, Christophe Debacq, et al.
Retrovirology|April 23, 2008
Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cellsTetsuya Usui, Katsunori Yanagihara, Kunihiro Tsukasaki, et al.
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Pageof 165